Noted : Actualité Noted en direct - P3 | Bourse Reflex
Accueil > Tags > Noted

  • Toutes les actualités en rapport avec « Noted »

31/08 18:05 Noted - January - June 2011 (H1) consolidated results

29/08 10:20 Noted - W.P. Stewart and Co., Ltd. Reports Second Half and Full Year 2010 Financial Results and Provides Corporate Update

11/08 18:05 Noted - January June 2011 (H1) turnover

08/08 16:05 Noted - Apricus Biosciences to File for Market Authorization to Sell Vitaros(R) for Erectile Dysfunction in Latin America

05/08 09:00 Noted - Apricus Biosciences Provides Corporate Mid-Year Update

28/07 18:50 Noted - Organic revenue growth of 5.6% in the second quarter of 2011. 15.5% increase in underlying attributable net income in the first half of 2011

18/07 18:00 Noted - 1st Quarter 2011/2012 - Total sales up 5.7%

07/07 18:10 Noted - Artprice confirms France's definitive approval of the Services Directive and its impact on the French auction market

20/06 08:35 Noted - Apricus Biosciences' CEO Sees Higher Revenue if Pfizer Viagra(R) Litigation is Successful

17/06 18:30 Noted - THEOLIA's General Meeting of shareholders

09/06 19:35 Noted - Exclusive interview of Thierry Ehrmann, the Founder and Ceo of Artprice.com

24/05 09:05 Noted - Innovative New i-PWER(TM) Low Profile Modular Power Supply Family Launched for Industrial and Communication Markets

20/05 16:00 Noted - Apricus Biosciences CEO is Interviewed on CDTV.net

20/05 13:30 Noted - New iPWER(TM) High-Efficiency 1200W Aspiro(TM) Rectifier Released With Aspiro Front Access Platform

19/05 14:45 Noted - Apricus Biosciences Receives Guidance From Swiss Regulatory Authorities Regarding Filing for Market Authorization of Vitaros(R) for Erectile Dysfunction in Switzerland

12/05 18:15 Noted - Turnover as of March 31, 2011

02/05 19:00 Noted - First quarter 2011 revenue: Growth of 3.5% to EUR 429.1 million

28/04 16:10 Noted - Apricus Biosciences Requests Approval of Vitaros(R) as a Treatment for Erectile Dysfunction in Europe

28/04 11:05 Noted - Apricus Biosciences Requests Approval of Vitaros(R) as a Treatment for Erectile Dysfunction in Europe

13/04 19:45 Noted - Apricus Biosciences Files for Orphan Drug Designation for RayVa(TM)